Figurate SCADA debuts to speed bioprocess digital transformation

Biopharma manufacturing software is having a very specific problem. The equipment got smarter, but the plant around it often stayed fragmented — one vendor’s skid here, another control package there, and a lot of manual stitching in between. That is bad for speed, bad for data integrity, and especially bad in an industry where every change can trigger validation work. So the news here is pretty concrete: Rockwell Automation and Cytiva said on April 29 that they are launching Figurate SCADA, a supervisory control layer meant to connect those pieces into one digital operating system for bioprocess plants. (cytivalifesciences.com) ### What is SCADA doing here? SCADA is the software layer that lets operators see, supervise, and coordinate equipment across a process instead of babysitting each machine on its own island. In bioprocessing, that means alarms, batch views, reporting, and real-time oversight across unit operations that may come from different suppliers. Figurate SCADA is meant to sit above that mixed equipment base and give teams one interface instead of a patchwork of proprietary screens. (cytivalifesciences.com) ### What problem are they actually fixing? The core issue is equipment fragmentation. Biopharma teams often buy best-of-breed tools over time, but those systems do not always talk to each other cleanly. The result is operational silos, manual workarounds, and messy data handoffs — exactly the stuff that slows invest(cytivalifesciences.com)tion. (cytivalifesciences.com) ### Why is “vendor-agnostic” the important phrase? Because nobody wants to rip out a validated plant just to modernize software. Cytiva says the platform is vendor-agnostic, and the launch materials stress support for multiple instrument vendors and modalities. Basically, the value proposition is not “buy an all-Cytiva factory.” It is “keep your mixed environment, but supervise it in one place.” That is a much easier sell in regulated manufacturing. (cytivalifesciences.com) ### What does the new platform include? The feature list is practical more than flashy — native integration with Cytiva equipment and Rockwell’s FactoryTalk stack, centralized alarms, real-time monitoring, batch reporting, pre-engineered templates, and modular deployment. The companies also say the same platform can stretch from process development into commercial manufacturing without a redesign, which matters because tech-transfer breaks a lot of digital continuity in biopharma. (cytivalifesciences.com) ### Is this a brand-new relationship? No — turns out this launch is the latest layer on a partnership that has been building for years. Rockwell and Cytiva were already working together by 2021 on automation platforms and a digital transformation center in Shanghai. Cytiva’s Figurate brand also already existed acros(cytivalifesciences.com)utomation stack. (rockwellautomation.com) ### Has any of this been used in the real world? Yes. The Testa Center in Uppsala has been using Cytiva’s Figurate automation platform with Rockwell’s PlantPAx and FactoryTalk environment as part of a standardized biomanufacturing setup. That earlier deployment included control, data acquisition, user management, recipe execution, cybersecurity, alarms, and reporting — basically the same digital spine this launch is now trying to package more broadly for customers. (automationworld.com) ### Why does this matter beyond software? Because in biopharma, workflow control can shape purchasing power. Once a consumable, instrument, or recipe sits inside a validated and software-observed process, swapping it out gets harder. A platform like this can make plants more efficient, but it can also strengthen the position of suppliers whose hardware and methods become embedded in the operating model. That is the strategic angle sitting underneath the product launch. (cytivalifesciences.com) ### Bottom line This is not just another dashboard. It is an attempt to make bioprocess plants behave like one system instead of a federation of expensive machines. If Figurate SCADA works as advertised, the payoff is faster deployment, cleaner data, and less friction moving from development to manufacturing — which is exactly where biopharma plants still lose time. (cytivalifesciences.com)